128 related articles for article (PubMed ID: 17523292)
1. The relationship between MIB-1 proliferative activity and mitotic index in gastrointestinal stromal tumors.
Filiz G; Yalçinkaya O; Gürel S; Yerci O; Memik F
Hepatogastroenterology; 2007 Mar; 54(74):438-41. PubMed ID: 17523292
[TBL] [Abstract][Full Text] [Related]
2. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors].
Liang YM; Li XH; Chen W
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1041-5. PubMed ID: 18754437
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of gastrointestinal stromal tumors.
Bertin M; Angriman I; Scarpa M; Mencarelli R; Ranzato R; Ruffolo C; Polese L; Iacobone M; D'Amico DF
Hepatogastroenterology; 2007; 54(73):124-8. PubMed ID: 17419245
[TBL] [Abstract][Full Text] [Related]
4. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients.
Song Z; Wang JL; Pan YL; Tao DY; Gan MF; Huang KE
Hepatogastroenterology; 2009; 56(89):149-53. PubMed ID: 19453047
[TBL] [Abstract][Full Text] [Related]
5. Serosal penetration is an important prognostic factor for gastrointestinal stromal tumors.
Vallböhmer D; Marcus HE; Baldus SE; Brabender J; Drebber U; Metzger R; Hölscher AH; Schneider PM
Oncol Rep; 2008 Oct; 20(4):779-83. PubMed ID: 18813818
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal stromal tumors: usefulness of immunohistochemistry, flow cytometry and fluorescence in situ hybridization.
Fontana MG; Rossi E; Bassotti G; Aquilano MC; Cadei M; Grigolato P; Villanacci V
J Gastroenterol Hepatol; 2007 Nov; 22(11):1754-9. PubMed ID: 17914946
[TBL] [Abstract][Full Text] [Related]
7. Audit of a series of 40 gastrointestinal stromal tumour cases.
Hinz S; Pauser U; Egberts JH; Schafmayer C; Tepel J; Fändrich F
Eur J Surg Oncol; 2006 Dec; 32(10):1125-9. PubMed ID: 16859873
[TBL] [Abstract][Full Text] [Related]
8. Significance of p53 expression in gastrointestinal stromal tumors.
Yalcinkaya U; Yerci O; Koc EU
Hepatogastroenterology; 2007; 54(73):140-3. PubMed ID: 17419248
[TBL] [Abstract][Full Text] [Related]
9. Prognostic assessment of gastrointestinal stromal tumor.
Yan H; Marchettini P; Acherman YI; Gething SA; Brun E; Sugarbaker PH
Am J Clin Oncol; 2003 Jun; 26(3):221-8. PubMed ID: 12796588
[TBL] [Abstract][Full Text] [Related]
10. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis.
Hassan I; You YN; Shyyan R; Dozois EJ; Smyrk TC; Okuno SH; Schleck CD; Hodge DO; Donohue JH
Ann Surg Oncol; 2008 Jan; 15(1):52-9. PubMed ID: 18000711
[TBL] [Abstract][Full Text] [Related]
11. Operative indications for relatively small (2-5 cm) gastrointestinal stromal tumor of the stomach based on analysis of 60 operated cases.
Otani Y; Furukawa T; Yoshida M; Saikawa Y; Wada N; Ueda M; Kubota T; Mukai M; Kameyama K; Sugino Y; Kumai K; Kitajima M
Surgery; 2006 Apr; 139(4):484-92. PubMed ID: 16627057
[TBL] [Abstract][Full Text] [Related]
12. P53 and MIB-1 expression in gastrointestinal stromal tumor (GIST) of the stomach.
Hata Y; Ishigami S; Natsugoe S; Nakajo A; Okumura H; Miyazono F; Matsumoto M; Hokita S; Aikou T
Hepatogastroenterology; 2006; 53(70):613-5. PubMed ID: 16995473
[TBL] [Abstract][Full Text] [Related]
13. Survival analysis of patients with duodenal gastrointestinal stromal tumors.
Miki Y; Kurokawa Y; Hirao M; Fujitani K; Iwasa Y; Mano M; Nakamori S; Tsujinaka T
J Clin Gastroenterol; 2010 Feb; 44(2):97-101. PubMed ID: 19809358
[TBL] [Abstract][Full Text] [Related]
14. Biological behavior due to cell proliferation markers of gastrointestinal stromal tumors.
Menéndez P; Padilla D; Cubo T; Villarejo P; Gambí D; Menéndez JM; Colina F; García M; Lora D; Martín J
Hepatogastroenterology; 2011; 58(105):76-80. PubMed ID: 21510290
[TBL] [Abstract][Full Text] [Related]
15. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).
Dematteo RP; Gold JS; Saran L; Gönen M; Liau KH; Maki RG; Singer S; Besmer P; Brennan MF; Antonescu CR
Cancer; 2008 Feb; 112(3):608-15. PubMed ID: 18076015
[TBL] [Abstract][Full Text] [Related]
16. Colorectal mesenchymal tumors - from smooth muscle tumors to stromal tumors.
Tai WC; Chuah SK; Lin JW; Chen HH; Huang HY; Kuo CM; Yi LN; Lee CM; Changchien CS; Hu TH
Oncol Rep; 2008 Nov; 20(5):1157-64. PubMed ID: 18949416
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors in gastrointestinal stromal tumors among a group of Mexican patients].
Medina-Franco H; Aguilar-Jiménez JR; Medina-Cuairán JZ
Gac Med Mex; 2009; 145(2):91-6. PubMed ID: 19518014
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
[TBL] [Abstract][Full Text] [Related]
19. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study of gastrointestinal stromal tumors].
Zhang W; Ye ZY; Shao QS; Zhao ZS; Wang YD; Xu XD
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jul; 12(4):378-81. PubMed ID: 19598024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
